– New Senate legislation that would restore consumers’ freedom to use pre-tax dollars from flexible spending accounts (FSAs) and health savings accounts (HSAs) to purchase over-the-counter (OTC) medicines without first seeing a doctor has been endorsed by the National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA).
The Restoring Access to Medication Act (S. 1647) was recently introduced
by U.S. Senators Mary Landrieu (D-La.) and Pat Roberts (R-Kan.). NACDS and NCPA are part of the Health Choices Coalition, which sent a letter of endorsement
to the bill’s leading sponsors. The coalition’s members also include organizations representing consumers, physicians, health insurance plans and employers.
“Consumers depend on OTC medicines as a first line of defense for their families’ health care needs,” the coalition wrote. “OTC medicines provide Americans with effective, affordable, convenient, and accessible means to address their health care needs. These medicines save consumers billions of dollars annually through reducing unnecessary doctors’ visits, less time lost from work, and the cost advantage of OTC medicines.”
The Affordable Care Act included a provision requiring patients to see a physician and obtain a prescription for an OTC, in order to pay for such medications using pre-tax dollars from a FSA or HSA. The change has inconvenienced patients and prompted complaints
from some physicians and patients to community pharmacists. NACDS has also long-supported this legislation
In its letter, the Health Choices Coalition added, “We believe this restriction on the use of tax-preferred accounts for the purchase of OTC medicines has resulted in unintended consequences to both physicians and patients. We thank you for your efforts to restore the ability to pay for OTC medicines with tax-preferred account funds without the need for a prescription. We remain committed to working with you and others in Congress to advance this legislation that will increase cost efficiencies in the health care system and give consumers control of their health care choices.”
The Senate bill mirrors H.R. 2835, introduced earlier this year by U.S. Reps. Lynn Jenkins (R-Kan.) and John Barrow (D-Ga.). Similar legislation passed the U.S. House of Representatives